T

TransMedics Group
D

TMDX

80.590
USD
-1.06
(-1.30%)
Post Trading·74.750USD-5.840(-7.25%)
حجم التداول
43,794
الربح لكل سهم
2
العائد الربحي
-
P/E
19
حجم السوق
2,785,263,817
المقالات
المزيد

العنوان: TransMedics Group

القطاع: الرعاية الصحية
الصناعة: Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The companyhas developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.